Showing 1 - 16 results of 16 for search 'Li-Xu Yan', query time: 0.06s Refine Results
  1. 1
    Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy

    Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy by Jian Su, Yi-Long Wu, Xu-Chao Zhang, Kai Yin, Si-Yang Liu, Li-Xu Yan, Xue-Ning Yang

    Published 2021-04-01
    Get full text
    Article
  2. 2
    VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma

    VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma by Ming Zhang, Hua-Jin Pang, Wei Zhao, Yu-Fa Li, Li-Xu Yan, Zhong-Yi Dong, Xiao-Feng He

    Published 2018-05-01
    Get full text
    Article
  3. 3
    Changes in erythrocyte deformability in patients with T2DM are associated with RBC energy metabolism

    Changes in erythrocyte deformability in patients with T2DM are associated with RBC energy metabolism by SUN Ming-yue, LI Xu-yan, SA Ru-la, LI Jing-jing, LIANG Hao, YAN Zhao-li, SU Yan

    Published 2021-02-01
    Get full text
    Article
  4. 4
    Material Selection and Evaluation on Internal Coating of Associated Gas Pipeline in H<sub>2</sub>S-CO<sub>2</sub>-O<sub>2</sub> Coexistence System in Tahe Oilfield

    Material Selection and Evaluation on Internal Coating of Associated Gas Pipeline in H<sub>2</sub>S-CO<sub>2</sub>-O<sub>2</sub> Coexistence System in Tahe Oilfield by XIAO Wen-wen, ZHANG Wen-bo, LIN De-yun, GE Peng-li, XU Yan-yan, LIAO Ke-xi, YANG-Na

    Published 2023-02-01
    Get full text
    Article
  5. 5
    Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.

    Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. by Zi-Ming Du, Li-Fu Hu, Hai-Yun Wang, Li-Xu Yan, Yi-Xin Zeng, Jian-Yong Shao, Ingemar Ernberg

    Published 2011-04-01
    Get full text
    Article
  6. 6
    Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.

    Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. by Li-Xu Yan, Yan-Hui Liu, Dong-Lan Luo, Fen Zhang, Yu Cheng, Xin-Lan Luo, Jie Xu, Jie Cheng, Heng-Guo Zhuang

    Published 2018-01-01
    Get full text
    Article
  7. 7
    Correlation Analysis on the Main Controlling Factors on Corrosion of High Sulfur Associated Gas Pipeline in Tahe Oilfield

    Correlation Analysis on the Main Controlling Factors on Corrosion of High Sulfur Associated Gas Pipeline in Tahe Oilfield by CHENG Xiao - jun, XIAO Wen - wen, ZENG Wen - guang, LIU Qing - shan, LIAO Ke - xi, CHEN Wei, GE Peng - li, XU Yan - yan, YANG Na

    Published 2022-06-01
    Get full text
    Article
  8. 8
    Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors

    Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors by Ben‐Yuan Jiang, Jia‐Tao Zhang, Li‐Xu Yan, Xiang‐Peng Chu, Qiang Nie, Jian‐Xiu Cui, Xue‐Ning Yang, Wen‐Zhao Zhong, Yi‐Long Wu

    Published 2021-11-01
    Get full text
    Article
  9. 9
    Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma

    Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma by Mu-Yan Cai, Feng-Wei Wang, Chang-Peng Li, Li-Xu Yan, Jie-Wei Chen, Rong-Zhen Luo, Jing-Ping Yun, Yi-Xin Zeng, Dan Xie

    Published 2016-08-01
    Get full text
    Article
  10. 10
    Prognostic and predictive values of a multimodal nomogram incorporating tumor and peritumor morphology with immune status in resectable lung adenocarcinoma

    Prognostic and predictive values of a multimodal nomogram incorporating tumor and peritumor morphology with immune status in resectable lung adenocarcinoma by Xin Chen, Wei Zhao, Jun Liu, Junjie Hua, Yumeng Wang, Huan Lin, Mingwei Chen, Zaiyi Liu, Shiwei Luo, Yanting Liang, LiXu Yan, Deqing Hong, Xipeng Pan

    Published 2025-03-01
    Get full text
    Article
  11. 11
    Dynamic 18F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer

    Dynamic 18F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer by Zhi‐Yong Chen, Rui Fu, Xiao‐Yue Tan, Li‐Xu Yan, Wen‐Fang Tang, Zhen‐Bin Qiu, Yi‐Fan Qi, Yu‐Fa Li, Qing‐Yi Hou, Yi‐Long Wu, Wen‐Zhao Zhong, Ben‐Yuan Jiang

    Published 2022-09-01
    Get full text
    Article
  12. 12
    EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer

    EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer by Zhong-Yi Dong, Jia-Tao Zhang, Si-Yang Liu, Jian Su, Chao Zhang, Zhi Xie, Qing Zhou, Hai-Yan Tu, Chong-Rui Xu, Li-Xu Yan, Yu-Fa Li, Wen-Zhao Zhong, Yi-Long Wu

    Published 2017-11-01
    Get full text
    Article
  13. 13
    Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinoma

    Spatial downregulation of CD74 signatures may drive invasive component development in part-solid lung adenocarcinoma by Jia-Tao Zhang, Juan Zhang, Song-Rong Wang, Li-Xu Yan, Jing Qin, Kai Yin, Xiang-Peng Chu, Meng-Min Wang, Hui-Zhao Hong, Zhi-Yi Lv, Song Dong, Ben-Yuan Jiang, Xu-Chao Zhang, Xiang Liu, Qing Zhou, Yi-Long Wu, Wen-Zhao Zhong

    Published 2023-10-01
    Get full text
    Article
  14. 14
    Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis

    Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis by Chao Zhang, Hua-Fei Chen, Shi Yan, Lin Wu, Li-Xu Yan, Xiao-Long Yan, Dong-Sheng Yue, Chun-Wei Xu, Min Zheng, Ji-Sheng Li, Si-Yang Liu, Ling-Ling Yang, Ben-Yuan Jiang, Qiu-Xiang Ou, Zhen-Bin Qiu, Yang Shao, Yi-Long Wu, Wen-Zhao Zhong

    Published 2022-09-01
    Get full text
    Article
  15. 15
    Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study

    Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study by Si-Yang Liu, Song Dong, Xue-Ning Yang, Ri-Qiang Liao, Ben-Yuan Jiang, Qun Wang, Xiao-Song Ben, Gui-Bin Qiao, Jun-Tao Lin, Hong-Hong Yan, Li-Xu Yan, Qiang Nie, Hai-Yan Tu, Bin-Chao Wang, Jin-Ji Yang, Qing Zhou, Hong-Rui Li, Ke Liu, Wendy Wu, Si-Yang Maggie Liu, Wen-Zhao Zhong, Yi-Long Wu

    Published 2023-12-01
    Get full text
    Article
  16. 16
    Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma

    Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma by Jia-Xin Lin, PhD, Kai Yin, PhD, Li-Xu Yan, PhD, Mei-Mei Zheng, PhD, Yang-Si Li, PhD, Shi-Ling Zhang, MS, Kang-Hui Zeng, MS, Hong-Hong Yan, MS, Hai-Yan Tu, PhD, Zhi-Hong Chen, MS, Xu-Chao Zhang, PhD, Qing Zhou, PhD, Jin-Ji Yang, PhD, Ben-Yuan Jiang, PhD, Qing-Ling Zhang, PhD, Yi-Long Wu, MD

    Published 2024-09-01
    Get full text
    Article

Search Tools: